Please wait a minute...
European Journal of Gynaecological Oncology  2019, Vol. 40 Issue (5): 867-869    DOI: 10.12892/ejgo4595.2019
Case Report Previous articles | Next articles
Lumbosacral neuropathy and buttock necrosis after internal iliac arterial embolization in abundant bleeding cervical carcinoma
Ş. Gezer1, *(), Ö. Çakır2
1Fellow in Gynecologic Oncology, Department of Obstetrics and Gynecology, Kocaeli University School of Medicine, Kocaeli, Turkey
2Department of Radiology, Kocaeli University School of Medicine, Kocaeli, Turkey
Download:  PDF(998KB)  ( 209 ) Full text   ( 4 )
Export:  BibTeX | EndNote (RIS)      
Abstract  

Objective: In advanced cases of cervical carcinoma, the tumor may cause massive bleeding requiring blood transfusion. When conservative management is ineffective, internal iliac arterial embolization (IIAE) may be life-saving. Case Report: The case of lumbosacral neuropathy and buttock necrosis that developed after IIAE. The posterior branch of the internal iliac artery gives the superior gluteal artery, ilio-lumbar artery, and lateral sacral artery. It was anticipated that the gluteal necrosis and neuropathy in this case developed due to ischemic damage with the occlusion of the posterior branch of the internal iliac artery by the embolizing agent. The use of selective embolization where nutrition of the posterior branch of internal iliac artery is preserved, will prevent similar complications.

Key words:  Cervical cancer      Buttock necrosis      Neuropathy      Internal iliac artery embolization     
Published:  10 October 2019     
*Corresponding Author(s):  Ş. GEZER     E-mail:  dr.senergezer@gmail.com

Cite this article: 

Ş. Gezer, Ö. Çakır. Lumbosacral neuropathy and buttock necrosis after internal iliac arterial embolization in abundant bleeding cervical carcinoma. European Journal of Gynaecological Oncology, 2019, 40(5): 867-869.

URL: 

https://ejgo.imrpress.com/EN/10.12892/ejgo4595.2019     OR     https://ejgo.imrpress.com/EN/Y2019/V40/I5/867

[1] Eda Kucuktulu, Ahmet Fatih Yurekli. Simultaneous Integrated Intensity Modulated Radiotherapy Boost for Gynecological Cancer when Brachytherapy is not an Option[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 720-725.
[2] Wook Youn Kim, Shin Hee Seo, Seung-Hyuk Shim, Jin Hee Park, Hyung Kyu Park, Kyeong A So, Tae Jin Kim, Sun Joo Lee. Correlation of immunohistochemistry and silver in situ hybridization for the assessment of c-MET in uterine cervical cancer patients treated with radical hysterectomy[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 745-752.
[3] John P. Micha, Howard D. Epstein, Michael C. Roossin, Randy Bohart, Mark A. Rettenmaier, Bram H. Goldstein. Neoadjuvant chemotherapy, radical hysterectomy and chemoradiation for stage iva cervical carcinoma[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 797-801.
[4] Juan Xu, Qingqing Tan, Ting Li. USP22 promotes the expression of GLUT1 and HK2 to facilitate growth and glycolysis in cervical cancer cells[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 790-796.
[5] Yan qin Zhang, Di Wu, Meng qi Deng, Xiang yu Chang, Jin wei Miao, Yu mei Wu. Individual management of cervical cancer during pregnancy[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 833-837.
[6] Yi-fan Luo, Li-xiang Ren, Ming-yan Jiang, Yang Chu. A systematic review and meta-analysis on the effects of metformin on survival outcomes and risk in women with cervical cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 504-507.
[7] Liman Yang, Jing Jin, Juhong Liu. Correlation of MMP2-C1306T (rs243865) and MMP7-181A/G (rs11568818) with cervical cancer: a meta-analysis[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 508-512.
[8] Panteleimon Mnimatidis, Abraham Pouliakis, George Valasoulis, George Michail, Aris Spathis, Christine Cottaridi, Niki Margari, Maria Kyrgiou, Maria Nasioutziki, Alexandros Daponte, Konstantinos Dinas, Evangelos Paraskevaidis, Ioannis Panayiotides, Dimitrios-Dionysios Koutsouris. Multicentric assessment of cervical HPV infection co-factors in a large cohort of Greek women[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 545-555.
[9] Fengmei Wang , Huachun Luo , Huihua Cheng, Huijuan Huang , Zhichao Fu. Is 3D printing-gided three-dimensional brachytherapy suitable for cervical cancer: from one single research institute?[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 591-597.
[10] Hiroshi Yoshida, Megumi Yamamoto, Hiroyuki Shigeta. Successful treatment of uterine cervical carcinoma with extensive vaginal lesions using laparoscopic surgery: A case report[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 629-633.
[11] Hikari Unno, Seiji Mabuchi, Isao Arai, Tomoko Wakasa, Seiichi Yamamasu. Development of lymphangiosarcoma after pelvic radiation therapy for uterine cervical cancer: A case report and literature review[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 326-331.
[12] L. Xu, H. Cai, N. Zhu, Bo Zheng. Interleukin-22 derived from cervical cancer-associated fibroblasts accelerates senescence of normal fibroblasts and promotes expression of tumorigenesis-related factors in HeLa cells[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 192-199.
[13] Hong Yan, Chunhua Zhang, Tingting Liu, Jianzhong Liu. Mifepristone regulates the multidrug resistance via miR-758/MEPE of Hela cell lines[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 214-220.
[14] K. Plagens–Rotman, M. Piskorz–Szymendera, B. PIĘTA. Lifestyle with particular emphasis on physical activity and genital carcinomas in women[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 233-239.
[15] B. Bárány, R. Póka. Nutritional assessment among patients with cervical cancer and controls[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 23-29.
No Suggested Reading articles found!